Professor Bruce Russell

Contact Details
- Phone
- +64 3 479 7272
- bruce.russell@otago.ac.nz
University Links
- Position
- Associate Dean, Clinical Pharmacy
- Qualifications
- BPharm(Hons) PhD
- Research summary
- Biomarkers that enable the prediction of a response to treatment for severe mental health disorders
- Teaching
- I teach clinical pharmacy to third and fourth year students.
- Memberships
- Member of the Schizophrenia International Research Society (SIRS)
- Member of the College of Problems on Drug Dependence, USA
- Member of the Pharmaceutical Society of New Zealand
- Clinical
- The majority of my research is with patients so I regularly engage with service user groups and enjoy talking to carers and clinical staff whenever possible.
Research
My research focuses on investigating the psychopharmacology and underlying pathophysiology of the severe mental illnesses such as schizophrenia with an emphasis on treatment-resistance. I aim to discover biomarkers that will enable the prediction of an individual's response to drug treatment. I also have an active interest in the psychopharmacology of both new and 'old' recreationally used drugs and the mechanisms underlying drug addiction.
Publications
Merritt, K., McCutcheon, R. A., Aleman, A., Ashley, S., Beck, K., Block, W., … Russell, B. R., … the 1H-MRS in Schizophrenia Investigators. (2023). Variability and magnitude of brain glutamate levels in schizophrenia: A meta and mega-analysis. Molecular Psychiatry. Advance online publication. doi: 10.1038/s41380-023-01991-7
Harrison, O., Russell, B. R., & Pattinson, K. T. S. (2022). Perceptual and ventilatory responses to hypercapnia in athletes and sedentary individuals. Frontiers in Physiology, 13, 820307. doi: 10.3389/fphys.2022.820307
Maharjan, A., Peng, M., Russell, B., & Cakmak, Y. O. (2022). Investigation of the optimal parameters of median nerve stimulation using a variety of stimulation methods and its effects on heart rate variability: A systematic review. Neuromodulation, 25, 1268-1279. doi: 10.1016/j.neurom.2021.10.005
Shadli, S. M., Ando, L. C., McIntosh, J., Lodhia, V., Russell, B. R., Kirk, I. J., Glue, P., & McNaughton, N. (2021). Right frontal anxiolytic-sensitive EEG 'theta' rhythm in the stop-signal task is a theory-based anxiety disorder biomarker. Scientific Reports, 11, 19746. doi: 10.1038/s41598-021-99374-x
Merritt, K., McGuire, P. K., Egerton, A., and the 1H-MRS in Schizophrenia Investigators, including Russell, B. R. (2021). Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: A mega-analysis of individual participant-level data. JAMA Psychiatry, 78(6), 667-681. doi: 10.1001/jamapsychiatry.2021.0380
McNabb, C. B., Smith, E. R., & Russell, B. R. (2019). Management of mental health disorders and the pharmacist's role: Schizophrenia. In Z. U.-D. Babar (Ed.), Encyclopedia of pharmacy practice and clinical pharmacy (Vol. 3: Part A). (1st ed.) (pp. 686-698). Amsterdam, The Netherlands: Elsevier. doi: 10.1016/B978-0-12-812735-3.00550-1
Chapter in Book - Research
Dalley, J. W., & Russell, B. (2014). Molecular imaging studies in stimulant addiction: A cross-species perspective. In R. A. J. O. Dierckx, A. Otte, E. F. J. de Vries, A. van Waarde & J. A. den Boer (Eds.), PET and SPECT in psychiatry. (pp. 515-534). Berlin, Germany: Springer. doi: 10.1007/978-3-642-40384-2_22
Chapter in Book - Research
Lin, J. C., & Russell, B. R. (2012). Stimulants: Neuroimaging and treatments. In J. J. Canales (Ed.), Emerging targets for drug addiction treatment. (pp. 17-62). Nova Science.
Chapter in Book - Research
Merritt, K., McCutcheon, R. A., Aleman, A., Ashley, S., Beck, K., Block, W., … Russell, B. R., … the 1H-MRS in Schizophrenia Investigators. (2023). Variability and magnitude of brain glutamate levels in schizophrenia: A meta and mega-analysis. Molecular Psychiatry. Advance online publication. doi: 10.1038/s41380-023-01991-7
Journal - Research Article
Harrison, O., Russell, B. R., & Pattinson, K. T. S. (2022). Perceptual and ventilatory responses to hypercapnia in athletes and sedentary individuals. Frontiers in Physiology, 13, 820307. doi: 10.3389/fphys.2022.820307
Journal - Research Article
Maharjan, A., Peng, M., Russell, B., & Cakmak, Y. O. (2022). Investigation of the optimal parameters of median nerve stimulation using a variety of stimulation methods and its effects on heart rate variability: A systematic review. Neuromodulation, 25, 1268-1279. doi: 10.1016/j.neurom.2021.10.005
Journal - Research Article
Merritt, K., McGuire, P. K., Egerton, A., and the 1H-MRS in Schizophrenia Investigators, including Russell, B. R. (2021). Association of age, antipsychotic medication, and symptom severity in schizophrenia with proton magnetic resonance spectroscopy brain glutamate level: A mega-analysis of individual participant-level data. JAMA Psychiatry, 78(6), 667-681. doi: 10.1001/jamapsychiatry.2021.0380
Journal - Research Article
Ram, S., Russell, B. R., Stewart, K., Kirkpatrick, C., Henning, M., Scahill, S., & Hussainy, S. (2021). Psychiatrists’ attitudes towards and willingness to prescribe cognitive enhancers in academic settings. Drugs: Education, Prevention, & Policy, 28(1), 59-66. doi: 10.1080/09687637.2020.1735303
Journal - Research Article
Searchfield, G. D., Spiegel, D. P., Poppe, T. N. E. R., Durai, M., Jensen, M., Kobayashi, K., … Russell, B. R., … Wise, K. J. (2021). A proof-of-concept study comparing tinnitus and neural connectivity changes following multisensory perceptual training with and without a low-dose of fluoxetine. International Journal of Neuroscience, 131(5), 433-444. doi: 10.1080/00207454.2020.1746310
Journal - Research Article
Shadli, S. M., Ando, L. C., McIntosh, J., Lodhia, V., Russell, B. R., Kirk, I. J., Glue, P., & McNaughton, N. (2021). Right frontal anxiolytic-sensitive EEG 'theta' rhythm in the stop-signal task is a theory-based anxiety disorder biomarker. Scientific Reports, 11, 19746. doi: 10.1038/s41598-021-99374-x
Journal - Research Article
McNabb, C. B., McIlwain, M. E., Anderson, V. M., Kydd, R. R., Sundram, F., & Russell, B. R. (2020). Aberrant white matter microstructure in treatment-resistant schizophrenia. Psychiatry Research: Neuroimaging, 305, 111198. doi: 10.1016/j.pscychresns.2020.111198
Journal - Research Article
Ram, S., Russell, B., Kirkpatrick, C., Stewart, K., Scahill, S., Henning, M., … Hussainy, S. (2020). Professionals' attitudes towards the use of cognitive enhancers in academic settings. PLoS ONE, 15(11), e0241968. doi: 10.1371/journal.pone.0241968
Journal - Research Article
Sabrini, S., Russell, B., Wang, G. Y., Lin, J., Kirk, I., & Curley, L. (2020). Methamphetamine induces neuronal death: Evidence from rodent studies. NeuroToxicology, 77, 20-28. doi: 10.1016/j.neuro.2019.12.006
Journal - Research Article
Searchfield, G. D., Poppe, T. N. E. R., Durai, M., Jensen, M., Kennedy, M. A., Maggo, S., Miller, A. L., … Russell, B. R., … Wise, K. (2020). A proof-of-principle study of the short-term effects of 3,4-methylenedioxymethamphetamine (MDMA) on tinnitus and neural connectivity. International Journal of Neuroscience, 130(7), 671-682. doi: 10.1080/00207454.2019.1702544
Journal - Research Article
Lagas, A. K., Black, J. M., Russell, B. R., Kydd, R. R., & Thompson, B. (2019). The effect of combined patching and citalopram on visual acuity in adults with amblyopia: A randomized, crossover, placebo-controlled trial. Neural Plasticity, 2019, 5857243. doi: 10.1155/2019/5857243
Journal - Research Article
Ram, S., Hussainy, S., Henning, M., Jensen, M., Stewart, K., & Russell, B. (2019). Cognitive enhancers (CE) and learning strategies. Journal of Cognitive Enhancement, 3(1), 124-130. doi: 10.1007/s41465-018-0089-9
Journal - Research Article
Spriggs, M. J., Thompson, C. S., Moreau, D., McNair, N. A., Wu, C. C., Lamb, Y. N., … Russell, B. R., … Kirk, I. J. (2019). Human sensory LTP predicts memory performance and is modulated by the BDNF Val66Met polymorphism. Frontiers in Human Neuroscience, 13, 22. doi: 10.3389/fnhum.2019.00022
Journal - Research Article
McNabb, C. B., Kydd, R., Sundram, F., Soosay, I., & Russell, B. R. (2018). Differences in white matter connectivity between treatment-resistant and treatment-responsive subtypes of schizophrenia. Psychiatry Research: Neuroimaging, 283, 47-54. doi: 10.1016/j.pscychresns.2018.11.002
Journal - Research Article
McNabb, C. B., Sundram, F., Soosay, I., Kydd, R. R., & Russell, B. R. (2018). Increased sensorimotor network connectivity associated with clozapine eligibility in people with schizophrenia. Psychiatry Research: Neuroimaging, 275, 36-42. doi: 10.1016/j.pscychresns.2018.02.008
Journal - Research Article
McNabb, C. B., Tait, R. J., McIlwain, M. E., Anderson, V. M., Suckling, J., Kydd, R. R., & Russell, B. R. (2018). Functional network dysconnectivity as a biomarker of treatment resistance in schizophrenia. Schizophrenia Research, 195, 160-167. doi: 10.1016/j.schres.2017.10.015
Journal - Research Article
Sengupta, N., McNabb, C. B., Kasabov, N., & Russell, B. R. (2018). Integrating space, time, and orientation in spiking neural networks: A case study on multimodal brain data modeling. IEEE Transactions on Neural Networks & Learning Systems, 29(11), 5249-5263. doi: 10.1109/TNNLS.2018.2796023
Journal - Research Article
McIntosh, H. D., Russell, B. R., Cochran, J. R., & Sollers, III, J. J. (2017). The heart of the pressor effect: Acute caffeine ingestion and resting heart rate variability. Journal of Caffeine Research, 7(1), 23-30. doi: 10.1089/jcr.2016.0003
Journal - Research Article
Ram, S., Hussainy, S., Henning, M., Stewart, K., Jensen, M., & Russell, B. (2017). Attitudes toward cognitive enhancer use among New Zealand tertiary students. Substance Use & Misuse, 52(11), 1387-1392. doi: 10.1080/10826084.2017.1281313
Journal - Research Article
Curley, L. E., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2016). Using fMRI to compare the effects of benzylpiperazine with dexamphetamine: Their differences during the Stroop paradigm. Journal of Integrative Neuroscience, 15, 109. doi: 10.1142/S0219635216500084
Journal - Research Article
Doborjeh, M. G., Wang, G. Y., Kasabov, N. K., Kydd, R., & Russell, B. (2016). A spiking neural network methodology and system for learning and comparative analysis of EEG data from healthy versus addiction treated versus addiction not treated subjects. IEEE Transactions on Biomedical Engineering, 63(9), 1830-1841. doi: 10.1109/TBME.2015.2503400
Journal - Research Article
Lagas, A. K., Black, J. M., Byblow, W. D., Fleming, M. K., Goodman, L. K., Kydd, R. R., Russell, B. R., … Thompson, B. (2016). Fluoxetine does not enhance visual perceptual learning and triazolam specifically impairs learning transfer. Frontiers in Human Neuroscience, 10, 532. doi: 10.3389/fnhum.2016.00532
Journal - Research Article
Lee, H., Wang, G. Y., Curley, L. E., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2016). Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography. Psychopharmacology, 233(15), 2869-2877. doi: 10.1007/s00213-016-4335-5
Journal - Research Article
Lee, H., Wang, G. Y., Curley, L. E., Sollers, J. J., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2016). Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: A single-dose study. Psychopharmacology, 233(5), 863-871. doi: 10.1007/s00213-015-4165-x
Journal - Research Article
McGregor, A. L., Dysart, J., Tingle, M. D., Russell, B. R., Kydd, R. R., & Finucane, G. (2016). Varenicline improves motor and cognitive symptoms in early Huntington’s disease. Neuropsychiatric Disease & Treatment, 12, 2381-2386. doi: 10.2147/NDT.S111083
Journal - Research Article
Ram, S., Hussainy, S., Henning, M., Jensen, M., & Russell, B. (2016). Prevalence of cognitive enhancer use among New Zealand tertiary students. Drug & Alcohol Review, 35(3), 345-351. doi: 10.1111/dar.12294
Journal - Research Article
Wang, G. Y., Kydd, R. R., & Russell, B. R. (2016). Quantitative EEG and low-resolution electromagnetic tomography (LORETA) imaging of patients undergoing methadone treatment for opiate addiction. Clinical EEG & Neuroscience, 47(3), 180-187. doi: 10.1177/1550059415586705
Journal - Research Article
Anderson, V. M., Goldstein, M. E., Kydd, R. R., & Russell, B. R. (2015). Extensive gray matter volume reduction in treatment-resistant schizophrenia. International Journal of Neuropsychopharmacology, 18(7), pyv016. doi: 10.1093/ijnp/pyv016
Journal - Research Article
Anderson, V. M., McIlwain, M. E., Kydd, R. R., & Russell, B. R. (2015). Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders? Psychiatry Research, 230(3), 811-818. doi: 10.1016/j.psychres.2015.10.036
Journal - Research Article
Curley, L. E., Kydd, R. R., Robertson, M. C., Pillai, A., McNair, N., Lee, H., … Russell, B. R. (2015). Acute effects of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) using functional magnetic resonance imaging (fMRI) and the Stroop task: A pilot study. Psychopharmacology, 232(16), 2969-2980. doi: 10.1007/s00213-015-3933-y
Journal - Research Article
Goldstein, M. E., Anderson, V. M., Pillai, A., Kydd, R. R., & Russell, B. R. (2015). Glutamatergic neurometabolites in clozapine-responsive and -resistant schizophrenia. International Journal of Neuropsychopharmacology, 18(6), pyu117. doi: 10.1093/ijnp/pyu117
Journal - Research Article
Lin, J. C., Jan, R. K., Kydd, R. R., & Russell, B. R. (2015). Investigating the microstructural and neurochemical environment within the basal ganglia of current methamphetamine abusers. Drug & Alcohol Dependence, 149, 122-127. doi: 10.1016/j.drugalcdep.2015.01.026
Journal - Research Article
Turner, C. E., Russell, B. R., & Gant, N. (2015). Comparative quantification of dietary supplemented neural creatine concentrations with 1H-MRS peak fitting and basis spectrum methods. Magnetic Resonance Imaging, 33(9), 1163-1167. doi: 10.1016/j.mri.2015.06.018
Journal - Research Article
Wang, G. Y., Kydd, R., & Russell, B. R. (2015). Auditory event-related potentials in methadone substituted opiate users. Journal of Psychopharmacology, 29(9), 983-995. doi: 10.1177/0269881115587929
Journal - Research Article
Wang, G. Y., Kydd, R., & Russell, B. R. (2015). Resting EEG and ERPs findings in methadone-substituted opiate users: A review. Acta Neurologica Belgica, 115(4), 539-546. doi: 10.1007/s13760-015-0476-2
Journal - Research Article
Wang, G. Y., Kydd, R., Wouldes, T. A., Jensen, M., & Russell, B. R. (2015). Changes in resting EEG following methadone treatment in opiate addicts. Clinical Neurophysiology, 126(5), 943-950. doi: 10.1016/j.clinph.2014.08.021
Journal - Research Article
Jan, R. K., Lin, J. C., McLaren, D. G., Kirk, I. J., Kydd, R. R., & Russell, B. R. (2014). The effects of methylphenidate on cognitive control in active methamphetamine dependence using functional magnetic resonance imaging. Frontiers in Psychiatry, 5, 20. doi: 10.3389/fpsyt.2014.00020
Journal - Research Article
Wang, G. Y., Wouldes, T. A., Kydd, R., Jensen, M., & Russell, B. R. (2014). Neuropsychological performance of methadone-maintained opiate users. Journal of Psychopharmacology, 28(8), 789-799. doi: 10.1177/0269881114538541
Journal - Research Article
Curley, L. E., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2013). Differential responses to anticipation of reward after an acute dose of the designer drugs benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) alone and in combination using functional magnetic resonance imaging (fMRI). Psychopharmacology, 229(4), 673-685. doi: 10.1007/s00213-013-3128-3
Journal - Research Article
Miles, S. W., Sheridan, J., Russell, B., Kydd, R., Wheeler, A., Walters, C., … Tiihonen, J. (2013). Extended-release methylphenidate for treatment of amphetamine/methamphetamine dependence: A randomized, double-blind, placebo-controlled trial. Addiction, 108(7), 1279-1286. doi: 10.1111/add.12109
Journal - Research Article
Sun, Y., Evans, J., Russell, B., Kydd, R., & Connor, B. (2013). A benzodiazepine impairs the neurogenic and behavioural effects of fluoxetine in a rodent model of chronic stress. Neuropharmacology, 72, 20-28. doi: 10.1016/j.neuropharm.2013.04.021
Journal - Research Article
Wang, G. Y., Wouldes, T. A., & Russell, B. R. (2013). Methadone maintenance treatment and cognitive function: A systematic review. Current Drug Abuse Reviews, 6(3), 220-230. doi: 10.2174/18744737112059990020
Journal - Research Article
Young, S. A., Thrimawithana, T. R., Antia, U., Fredatovich, J. D., Na, Y., Neale, P. T., … Russell, B. (2013). Pharmaceutical quality of "party pills" raises additional safety concerns in the use of illicit recreational drugs. New Zealand Medical Journal, 126(1376). Retrieved from http://www.nzma.org.nz/journal
Journal - Research Article
Jan, R. K., Kydd, R. R., & Russell, B. R. (2012). Functional and structural brain changes associated with methamphetamine abuse. Brain Sciences, 2(4), 434-482. doi: 10.3390/brainsci2040434
Journal - Research Article
Jan, R. K., Lin, J. C., Miles, S. W., Kydd, R. R., & Russell, B. R. (2012). Striatal volume increases in active methamphetamine-dependent individuals and correlation with cognitive performance. Brain Sciences, 2(4), 553-572. doi: 10.3390/brainsci2040553
Journal - Research Article
McNabb, C. B., Russell, B. R., Caprioli, D., Nutt, D. J., Gibbons, S., & Dalley, J. W. (2012). Single chemical entity legal highs: Assessing the risk for long term harm. Current Drug Abuse Reviews, 5(4), 304-319. doi: 10.2174/1874473711205040005
Journal - Research Article
Ram, S., Russell, B., Gubb, M., Taylor, R., Butler, C., Khan, I., & Shelling, A. (2012). General practitioner attitudes to direct-to-consumer genetic testing in New Zealand. New Zealand Medical Journal, 125(1364), 14-26. Retrieved from http://www.nzma.org.nz/journal
Journal - Research Article
Lee, H., Kydd, R. R., Lim, V. K., Kirk, I. J., & Russell, B. R. (2011). Effects of trifluoromethylphenylpiperazine (TFMPP) on interhemispheric communication. Psychopharmacology, 213(4), 707-714. doi: 10.1007/s00213-010-2025-2
Journal - Research Article
Lin, J. C., Jan, R. K., Kydd, R. R., & Russell, B. R. (2011). Subjective effects in humans following administration of party pill drugs BZP and TFMPP alone and in combination. Drug Testing & Analysis, 3(9), 582-585. doi: 10.1002/dta.285
Journal - Research Article
Lin, J. C., Jan, R. K., Lee, H., Jensen, M.-A., Kydd, R. R., & Russell, B. R. (2011). Determining the subjective and physiological effects of BZP combined with TFMPP in human males. Psychopharmacology, 214(3), 761-768. doi: 10.1007/s00213-010-2081-7
Journal - Research Article
McIlwain, M. E., Harrison, J., Wheeler, A. J., & Russell, B. R. (2011). Pharmacotherapy for treatment-resistant schizophrenia. Neuropsychiatric Disease & Treatment, 7(1), 135-149. doi: 10.2147/NDT.S12769
Journal - Research Article
Thornley, S., Russell, B., & Kydd, R. (2011). Carbohydrate reward and psychosis: An explanation for neuroleptic induced weight gain and path to improved mental health? Current Neuropharmacology, 9(2), 370-375. doi: 10.2174/157015911795596513
Journal - Research Article
Anita, U., Tingle, M. D., & Russell, B. R. (2010). Validation of an LC-MS method for the detection and quantification of BZP and TFMPP and their hydroxylated metabolites in human plasma and its application to the pharmacokinetic study of TFMPP in humans. Journal of Forensic Sciences, 55(5), 1311-1318. doi: 10.1111/j.1556-4029.2010.01457.x
Journal - Research Article
Jan, R. K., Lin, J. C., Lee, H., Sheridan, J. L., Kydd, R. R., Kirk, I. J., & Russell, B. R. (2010). Determining the subjective effects of TFMPP in human males. Psychopharmacology, 211(3), 347-353. doi: 10.1007/s00213-010-1911-y
Journal - Research Article
Anita, U., Tingle, M. D., & Russell, B. R. (2009). 'Party pill' drugs: BZP and TFMPP. New Zealand Medical Journal, 123, 1307, 55-68.
Journal - Research Article
Antia, U., Lee, H. S., Kydd, R. R., Tingle, M. D., & Russell, B. R. (2009). Pharmacokinetics of 'party pill' drug N-benzylpiperazine (BZP) in healthy human participants. Forensic Science International, 186(1-3), 63-67. doi: 10.1016/j.forsciint.2009.01.015
Journal - Research Article
Antia, U., Tingle, M. D., & Russell, B. R. (2009). In vivo interactions between BZP and TFMPP (party pill drugs). New Zealand Medical Journal, 122(1303), 29-38. Retrieved from https://www.nzma.org.nz/journal
Journal - Research Article
Antia, U., Tingle, M. D., & Russell, B. R. (2009). Metabolic interactions with piperazine-based 'party pill' drugs. Journal of Pharmacy & Pharmacology, 61(7), 877-882. doi: 10.1211/jpp/61.07.0006
Journal - Research Article
Lin, J. C., Bangs, N., Lee, H., Kydd, R. R., & Russell, B. R. (2009). Determining the subjective and physiological effects of BZP on human females. Psychopharmacology, 207(3), 439-446. doi: 10.1007/s00213-009-1669-2
Journal - Research Article
Murphy, M., Antia, U., Chang, H.-Y., Han, J. Y., Ibrahim, A., Tingle, M., & Russell, B. (2009). Party pills and drug-drug interactions. New Zealand Medical Journal, 122(1293), 16-25. Retrieved from https://www.nzma.org.nz/journal
Journal - Research Article
Sheridan, J., Butler, R., Wilkins, C., & Russell, B. (2007). Legal piperazine-containing party pills: A new trend in substance misuse. Drug & Alcohol Review, 26(3), 335-343. doi: 10.1080/09595230701255791
Journal - Research Article
Russell, B. R., & Laverty, R. (2001). The effect of (R)-HA966 or ACEA 1021 on dexfenfluramine or (S)-MDMA-induced changes in temperature, activity and neurotoxicity. Pharmacology Biochemistry & Behavior, 68(3), 565-574. doi: 10.1016/S0091-3057(01)00454-3
Journal - Research Article
Russell, B. R., & Laverty, R. (2000). Correlation between 5-HT content and uptake site density following (S)-MDMA and dexfenfluramine-induced depletion, and with neuroprotection by the glycine site-specific NMDA antagonist ACEA 1021. Annals of the New York Academy of Sciences, 914, 208-214. doi: 10.1111/j.1749-6632.2000.tb05197.x
Journal - Research Article
Zheng, Y., Russell, B., Schmierer, D., & Laverty, R. (1997). The effects of aminorex and related compounds on brain monoamines and metabolites in CBA mice. Journal of Pharmacy & Pharmacology, 49(1), 89-96. doi: 10.1111/j.2042-7158.1997.tb06758.x
Journal - Research Article
Russell, B. R., Beresford, R. A., Schmierer, D. M., McNaughton, N., & Clark, C. R. (1995). Stimulus properties of some analogues of 4-methylaminorex. Pharmacology Biochemistry & Behavior, 51(2-3), 375-378. doi: 10.1016/0091-3057(94)00407-A
Journal - Research Article
Glue, P., Russell, B., & Medlicott, N. J. (2021). Influence of formulation and route of administration on ketamine's safety and tolerability: Systematic review. European Journal of Clinical Pharmacology, 77, 671-676. doi: 10.1007/s00228-020-03047-z
Journal - Research Other
Wilkins, C., Sheridan, J., Adams, P., Russell, B., & Newcombe, D. (2013). Reply to Sumnall (2013): 'The New Zealand new psychoactive substances regime: A step in the right direction, but questions still remain'. Journal of Psychopharmacology, 27(11), 1078-1079. doi: 10.1177/0269881113503507a
Journal - Research Other
Wilkins, C., Sheridan, J., Adams, P., Russell, B., Ram, S., & Newcombe, D. (2013). The new psychoactive substances regime in New Zealand: A different approach to regulation [Perspective]. Journal of Psychopharmacology, 27(7), 584-589. doi: 10.1177/0269881113491441
Journal - Research Other
Sheridan, J., Atmore, B., & Russell, B. (2012). New Zealand to establish fit for purpose regulation for new psychoactive substances. Addiction, 107(11), 1901-1902. doi: 10.1111/j.1360-0443.2012.03809.x
Journal - Research Other
Hardy, I., Alany, R., Russell, B., & Hardy, G. (2006). Antimicrobial effects of arginine and nitrogen oxides and their potential role in sepsis [Editorial]. Current Opinion in Clinical Nutrition & Metabolic Care, 9(3), 225-232. doi: 10.1097/01.mco.0000222104.23171.58
Journal - Research Other